BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 6:06:00 PM | Browse: 1015 | Download: 952
Publication Name World Journal of Stem Cells
Manuscript ID 6079
Country United States
Received
2013-10-01 19:22
Peer-Review Started
2013-10-01 21:21
To Make the First Decision
2013-10-14 14:13
Return for Revision
2013-10-16 14:26
Revised
2013-10-23 01:40
Second Decision
2013-11-04 16:25
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-11-05 08:44
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-01-10 15:04
Publish the Manuscript Online
2014-02-15 15:06
ISSN 1948-0210 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Research & Experimental Medicine
Manuscript Type Topic Highlights
Article Title Dendritic cells derived from pluripotent stem cells: potential of large scale production
Manuscript Source Invited Manuscript
All Author List Yan Li, Meimei Liu and Shang-Tian Yang
Funding Agency and Grant Number
Funding Agency Grant Number
FSU start up fund
FSU Research Foundation GAP award
National Science Foundation 1342192(In part)
Corresponding Author Shang-Tian Yang, Professor, Department of Chemical and Biomolecular Engineering, The Ohio State University, 140 West 19th Ave, Columbus, OH 43210, United States. yang.15@osu.edu
Key Words Pluripotent stem cells; dendritic cells; bioreactor; hematopoietic differentiation; large scale production
Core Tip Human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) are promising sources for hematopoietic cells. This review summarizes recent advances in differentiating hESCs and hiPSCs to dendritic cells (DCs), which are unique immune cells in the hematopoietic system and can be loaded with tumor specific antigen and used as vaccine for cancer immunotherapy. While autologous DCs from peripheral blood are limited in number, human PSC (hPSC)-derived DCs provide a novel alternative cell source for clinical application. Different strategies and effects of shear stress on large-scale production of hPSC-derived DCs in bioreactors are also discussed.
Publish Date 2014-02-15 15:06
Citation Li Y, Liu M, Yan Y, Yang ST. Neural differentiation from pluripotent stem cells: The role of natural and synthetic extracellular matrix. World J Stem Cells 2014; 6(1): 11-23
URL http://www.wjgnet.com/1948-0210/full/v6/i1/11.htm
DOI http://dx.doi.org/10.4252/wjsc.v6.i1.11
Full Article (PDF) WJSC-6-1.pdf
Full Article (Word) WJSC-6-1.doc
Manuscript File 6079-Review.docx
Answering Reviewers 6079-Answering reviewers.pdf
Copyright License Agreement 6079-Copyright Assignment.pdf
Peer-review Report 6079-Peer review(s).pdf
Scientific Editor Work List 6079-Scientific editor work list.doc